http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CY-1110787-T1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ee67657556b1933fb9899a3fe2146e75 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-706 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D403-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H17-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D403-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7048 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H17-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-706 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7048 |
| filingDate | 2010-09-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_140ad13f0d352c424d011bf938791a59 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_af7884e3010b0f7efbbd8fb7fe24dfe8 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_38324bcf250d618ddda3c5beae6ee309 |
| publicationDate | 2015-06-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CY-1110787-T1 |
| titleOfInvention | NEW MORPHIN PRODUCTS |
| abstract | The present invention relates to novel morphine-6 glucuronide derivatives, pharmaceutical compositions, and their uses. These derivatives have the following structures: wherein the whole of module (A), with the exception of X, is called MR36G-NR1R2-S-; R1 represents a saturated or unsaturated, straight or branched C1-C10 alkyl group; wherein the alkyl chain is optionally terminated by one or more heteroatom (s) selected from O, S and N; R2 represents a hydrogen, a (C1-C5) alkyl group, saturated or unsaturated, straight or branched; or an aryl, heteroaryl or (C1-C5) alkylaryl group; R3 represents a group Y (C = Z) R or YR, Y and Z represent independently xylene or sulfur, while R is a C 1 -C 6 alkyl group in straight or branched, saturated or unsaturated, provided that R 3 is other than O-CH 3; X represents a hydrogen, a -S-R 4 -W radical, or an MR36G-NR1R2-S- radical, wherein R4 is a C1-C8 alkyl group, saturated or unsaturated and may include amide, ester, ether bonds and W is either a δ receptor antagonist or a κ receptor antagonist, as well and one of the pharmaceutically acceptable salts thereof. |
| priorityDate | 2006-10-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 36.